Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Interest Expenses (2016 - 2025)

Sensus Healthcare has reported Interest Expenses over the past 9 years, most recently at -$183000.0 for Q2 2025.

  • For Q2 2025, Interest Expenses rose 12.44% year-over-year to -$183000.0; the TTM value through Dec 2025 reached -$367000.0, up 13.24%, while the annual FY2024 figure was -$932000.0, 6.05% up from the prior year.
  • Interest Expenses for Q2 2025 was -$183000.0 at Sensus Healthcare, up from -$184000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $103000.0 in Q4 2021 and troughed at -$382000.0 in Q4 2022.
  • A 5-year average of -$131100.0 and a median of -$183500.0 in 2025 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: surged 3507.21% in 2021 and later plummeted 24200.0% in 2023.
  • Year by year, Interest Expenses stood at $103000.0 in 2021, then crashed by 470.87% to -$382000.0 in 2022, then surged by 36.39% to -$243000.0 in 2023, then increased by 13.99% to -$209000.0 in 2024, then increased by 12.44% to -$183000.0 in 2025.
  • Business Quant data shows Interest Expenses for SRTS at -$183000.0 in Q2 2025, -$184000.0 in Q1 2025, and -$209000.0 in Q2 2024.